To determine the clinical impact of reduced CtIP expression in human breast cancer, we assessed the association between CtIP mRNA levels and clinical outcome in three independent breast cancer cohorts [25-27] with clinical information (GEO database). This evidence concerns the gene RBBP8 and breast carcinoma.